APLT Lead Plaintiff Deadline Approaching - Contact Robbins LLP for Information About the Pending Class Action Against Applied Therapeutics, Inc.

SAN DIEGO, Jan. 29, 2025 /PRNewswire/ -- Robbins LLP reminds investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024. Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases.For more information, submit a form, email attorney Aaron Dumas, Jr., or gi ...